Explore these stocks poised to benefit from innovations in biotech:
AstraZeneca:AstraZeneca is a leading biopharmaceutical company focused on developing innovative medicines, especially for rare diseases and metabolic disorders.
Novartis:Novartis is a global healthcare company pioneering innovative medical solutions, especially tackling rare genetic diseases through cutting-edge research and development.
Amgen:With a strong focus on rare diseases and oncology, Amgen aims to address significant unmet medical needs.
Pfizer:Pfizer is at the forefront of research and development, striving to bring groundbreaking treatments to patients with single gene defects, neuromuscular diseases, and hematologic disorders.
Vertex Pharmaceuticals:Vertex focuses on developing innovative treatments for cystic fibrosis, sickle cell disease, and beta thalassemia.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more